number 120511-73-1ATC code L02BG03PubChem 2187DrugBank APRD00016Chemical dataFormula C17H19N5Mol. mass 293.366 g/molSMILES eMolecules & PubChemPharmacokinetic arimidex 1mg 83-85%Protein binding 40%Metabolism 85% hepaticHalf life 72 hoursExcretion 11% renalTherapeutic considerationsPregnancy cat. ?Legal status Rx only.

cat. ?Legal status Rx only (U.S.)Routes oralAnastrozole (INN, trade name: Arimidex®) is a drug indicated in the off-label use arimidex 1mg reducing estrogens (in particular and more importantly, estradiol) in men. Excess estradiol in men can cause benign prostatic hyperplasia, arimidex 1mg and symptoms of hypogonadism. Some athletes and body builders will also use anastrozole as a part of their steroid cycle to reduce arimidex 1mg prevent symptoms of excess estrogens; in particular, gynecomastia and water retention.Study data currently suggests that dosages of 0.5mg to 1mg a day reduce serum estradiol by about 50% in men, which differs from arimidex 1mg typical reduction in postmenopausal women. However the reduction may be different arimidex 1mg men with grossly elevated estradiol (clinical data is currently lacking).[edit] Usage for menWhile arimidex 1mg indicated arimidex 1mg women, this drug has proven effective in arimidex 1mg treatment of the growth disorder is through hormones which may trigger the early onset the.

postmenopausal women with localized breast cancer who received either anastrozole, tamoxifen, or both.[1] After more.